| Rachel Gormley, MD | |
|
50 Sewall St, Portland, ME 04102-2645 | |
| (207) 775-3526 | |
| (207) 775-5658 |
| Full Name | Rachel Gormley |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 14 Years |
| Location | 50 Sewall St, Portland, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316267990 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0900X | Dermatology - Dermatopathology | MD20662 (Maine) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Associates, Llc | 4587698279 | 19 |
News Archive
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – is calling on the healthcare industry to lead by example and implement universal flu vaccination for healthcare workers.
A report in the July Annals of Neurology describes a serious adverse event experienced by a participant in a clinical trial that may raise a new caution about the use of antiepileptic drugs for conditions other than epilepsy.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration approved EDARBI for the treatment of hypertension, or high blood pressure, in adults.
A pair of topical medicines already alleviating skin conditions each may prove to have another, even more compelling use: instructing stem cells in the brain to reverse damage caused by multiple sclerosis.
Ligand Pharmaceuticals Incorporated today announced that its partner Pfizer, Inc. launched Viviant® (Bazedoxifene) in Japan for the treatment of postmenopausal osteoporosis. Under the brand name Conbriza®, the drug is also marketed in Spain through a co-promotion with Almirall, an international pharmaceutical company based in Spain.
› Verified 8 days ago
| Entity Name | Dermatology Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780635342 PECOS PAC ID: 4587698279 Enrollment ID: O20050922000163 |
News Archive
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – is calling on the healthcare industry to lead by example and implement universal flu vaccination for healthcare workers.
A report in the July Annals of Neurology describes a serious adverse event experienced by a participant in a clinical trial that may raise a new caution about the use of antiepileptic drugs for conditions other than epilepsy.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration approved EDARBI for the treatment of hypertension, or high blood pressure, in adults.
A pair of topical medicines already alleviating skin conditions each may prove to have another, even more compelling use: instructing stem cells in the brain to reverse damage caused by multiple sclerosis.
Ligand Pharmaceuticals Incorporated today announced that its partner Pfizer, Inc. launched Viviant® (Bazedoxifene) in Japan for the treatment of postmenopausal osteoporosis. Under the brand name Conbriza®, the drug is also marketed in Spain through a co-promotion with Almirall, an international pharmaceutical company based in Spain.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Gormley, MD 50 Sewall St, Portland, ME 04102-2645 Ph: (207) 775-3526 | Rachel Gormley, MD 50 Sewall St, Portland, ME 04102-2645 Ph: (207) 775-3526 |
News Archive
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – is calling on the healthcare industry to lead by example and implement universal flu vaccination for healthcare workers.
A report in the July Annals of Neurology describes a serious adverse event experienced by a participant in a clinical trial that may raise a new caution about the use of antiepileptic drugs for conditions other than epilepsy.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration approved EDARBI for the treatment of hypertension, or high blood pressure, in adults.
A pair of topical medicines already alleviating skin conditions each may prove to have another, even more compelling use: instructing stem cells in the brain to reverse damage caused by multiple sclerosis.
Ligand Pharmaceuticals Incorporated today announced that its partner Pfizer, Inc. launched Viviant® (Bazedoxifene) in Japan for the treatment of postmenopausal osteoporosis. Under the brand name Conbriza®, the drug is also marketed in Spain through a co-promotion with Almirall, an international pharmaceutical company based in Spain.
› Verified 8 days ago
Rachel Rubino Dunlap, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1601 Congress St, Portland, ME 04102 Phone: 207-661-0100 | |
Carmen J Rinaldi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 Sewall St, Portland, ME 04102 Phone: 207-775-3526 | |
Jennifer Woodbury Bragg, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 Sewall Street, Portland, ME 04102 Phone: 207-775-3526 | |
Lauren Ko, MD Dermatology Medicare: Medicare Enrolled Practice Location: 50 Sewall St, Portland, ME 04102 Phone: 207-775-3526 Fax: 207-775-5658 | |
Dr. Wiley Joseph Smith, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 Sewall St, Portland, ME 04102 Phone: 207-775-3526 Fax: 207-775-5658 | |
Christopher Jay Steen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 Sewall St, Dermatology Associates, Portland, ME 04102 Phone: 207-775-3526 |